Indication
Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma
1 clinical trial
8 products
1 drug
Clinical trial
A Phase II Trial to Evaluate Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast CancerStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Product
AbemaciclibProduct
AnastrozoleProduct
ExemestaneProduct
FulvestrantProduct
LetrozoleDrug
TamoxifenProduct
Estradiol